首页> 外国专利> METHOD FOR GENETIC TREATMENT USING THE AAV-XBP1S/GFP VIRUS AND USE THEREOF IN THE PREVENTION AND TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS

METHOD FOR GENETIC TREATMENT USING THE AAV-XBP1S/GFP VIRUS AND USE THEREOF IN THE PREVENTION AND TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS

机译：AAV-XBP1S / GFP病毒的遗传治疗方法及其在预防和治疗肌萎缩性侧索硬化症中的用途

页面导航

摘要
著录项
相似文献

摘要

This invention presents the method and use of the AAV-XBP1s/GFP virus, in the prevention and treatment of amyotrophic lateral sclerosis, as presented in the in vivo studies in FIG. 6.

机译：本发明提供了AAV-XBP1s / GFP病毒在预防和治疗肌萎缩性侧索硬化中的方法和用途，如图1的体内研究所示。 6。 展开▼

著录项

公开/公告号US2019030188A1

专利类型

公开/公告日2019-01-31

原文格式PDF

申请/专利权人 UNIVERSIDAD DE CHILE;
展开▼

申请/专利号US201615767086

发明设计人 CLAUDIO ANDRÉS HETZ FLORES;VICENTE SPIRO VALENZUELA PATERAKIS;
展开▼

申请日2016-09-30

分类号A61K48;C12N15/864;A61K9;A61P25;C12N9/02;

国家 US

入库时间 2022-08-21 12:05:22

相似文献

专利

外文文献

中文文献

1. 治疗肌萎缩性侧索硬化症的方法和抑制肌萎缩性侧索硬化症进展的方法 [P] . 中国专利： CN111356455A . 2020-06-30

2. 3-甲基-1-苯基-2-吡唑啉-5-酮原药的分析方法、肌萎缩性侧索硬化症的治疗和肌萎缩性侧索硬化症的进展抑制、以及含有3-甲基-1-苯基-2-吡唑啉-5-酮原药的药剂的制造方法 [P] . 中国专利： CN111788481A . 2020-10-16

3. Method for genetic treatment using the AAV-XBP1s/GFP virus and use thereof in the prevention and treatment of amyotrophic lateral sclerosis [P] . 美国专利： US10512698B2 . 2019-12-24

机译： AAV-XBP1s / GFP病毒的遗传治疗方法及其在肌萎缩性侧索硬化症的预防和治疗中的用途

4. METHOD FOR GENETIC TREATMENT USING THE AAV-XBP1S/GFP VIRUS AND USE THEREOF IN THE PREVENTION AND TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS [P] . 欧洲知识产权局专利： EP3360580A4 . 2019-03-13

机译： AAV-XBP1S / GFP病毒的遗传治疗方法及其在预防和治疗肌萎缩性侧索硬化症中的用途

5. Method for genetic treatment using the AAV-XBP1S/GFP virus and use thereof in the prevention and treatment of amyotrophic lateral sclerosis [P] . AU2016336063A1 . 2018-05-24

机译： AAV-XBP1S / GFP病毒的遗传治疗方法及其在肌萎缩性侧索硬化症的预防和治疗中的用途

1. Adipose-derived stem cell conditioned medium for the treatment of amyotrophic lateral sclerosis:pre-clinical evidence and potential for clinical application [J] . Chandler L. Walker 中国神经再生研究（英文版） . 2019,第009期

2. Therapeutic opportunities and challenges of induced pluripotent stem cells-derived motor neurons for treatment of amyotrophic lateral sclerosis and motor neuron disease [J] . Manoj Kumar Jaiswal 中国神经再生研究（英文版） . 2017,第005期

3. Autologous bone marrow mononuclear cells as neuroprotective treatment of amyotrophic lateral sclerosis [J] . Francisco José Ruiz-López, Miguel Blanquer 中国神经再生研究（英文版） . 2016,第004期

4. Prospects for bone marrow cell therapy in amyotrophic lateral sclerosis:how far are we from a clinical treatment? [J] . Fernanda Gubert, Marcelo F. Satiago 中国神经再生研究（英文版） . 2016,第008期

5. Identifying potential targets for prevention and treatment of amyotrophic lateral sclerosis based on a screen of medicare prescription drugs [J] . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration . 2020,第3a4期

6. Potential therapeutic drugs and methods for the treatment of amyotrophic lateral sclerosis. [J] . G Yacila, Y Sari Current medicinal chemistry . 2014,第31期

7. Human T-cell Lymphotropic Virus Type I Associated with Amyotrophic Lateral Sclerosis Syndrome: Immunopathological Aspects and Treatment Options [J] . Fernando Gonzalez Trujillo, Karen Parra Cortes, Yolima álvarez Pareja, Cureus. . 2020,第4期

8. Ginsenoside Rg1 Nanophytosome synthesis and their characterization: An initiative towards the treatment of Amyotrophic Lateral Sclerosis [C] . Nandan Amol Merchant, TK Kavya, Rachana Srinivasa, IEEE International Conference on Nanotechnology . 2021

9. Arylsulfanyl Pyrazolones Block Mutant SOD1 Aggregation and have Potential Application for the Treatment of Amyotrophic Lateral Sclerosis. [D] . Chen, Tian. 2011

10. Potential Therapeutic Drugs and Methods for the Treatment of Amyotrophic Lateral Sclerosis [O] . G. Yacila, Y. Sari -1

11. Human T-cell Lymphotropic Virus Type I Associated with Amyotrophic Lateral Sclerosis Syndrome: Immunopathological Aspects and Treatment Options [O] . Fernando Gonzalez Trujillo, Karen Parra Cortes, Yolima Álvarez Pareja, 2020

12. Preclinical Testing of a Translocator Protein Ligand for the Treatment of Amyotrophic Lateral Sclerosis. [R] . Gourion-Arsiquaud, D. 2017

1. Rethinking to riluzole mechanism of action: the molecular link among protein kinase CK1δ activity, TDP-43 phosphorylation, and amyotrophic lateral sclerosis pharmacological treatment [J] . Maicol Bissaro ,Stefano Moro . 中国神经再生研究：英文版 . 2019,第12期

2. 肌萎缩性侧索硬化症案 [C] . 刘岚 ,刘累耕 ,吕鸣 . 2009年全国针灸临床学术研讨会暨北京地区针灸名家学术推广会 . 2009

3. 1.三重经颅磁刺激技术对肌萎缩侧索硬化症上运动神经元损害的评价;2.重复经颅磁刺激对肌萎缩侧索硬化症的治疗研究 [A] . 王悦 . 2010